TSX:DOL • CA25675T1075
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DOLLARAMA INC (DOL.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-12 | ARC INDEPENDENT RESEARCH | Maintains | Hold -> Hold |
| 2025-12-12 | Veritas Investment Research | Maintains | Buy -> Buy |
| 2025-04-06 | CIBC Capital Markets | Maintains | Neutral -> Neutral |
| 2025-04-06 | Veritas Investment Research | Maintains | Buy -> Buy |
| 2023-08-29 | National Bank Financial | Maintains | Outperform -> Outperform |
| 2022-12-08 | Stifel Nicolaus Research | Upgrade | |
| 2022-12-08 | RBC Royalbank | Upgrade | Outperform |
| 2022-12-08 | National Bank of Canada Financial | Upgrade | Outperform |
| 2022-12-08 | TD Research | Upgrade | Hold |
| 2022-12-08 | CIBC Capital Markets | Upgrade | Neutral |
| 2022-12-08 | Wells Fargo | Upgrade | |
| 2022-12-07 | CIBC Capital Markets | Maintains | Neutral |
| 2022-12-01 | Scotiabank Capital | Maintains | Outperform |
| 2022-12-01 | STA Research | Maintains | Buy |
| 2022-11-30 | National Bank of Canada Financial | Upgrade | |
| 2022-11-29 | Stifel Nicolaus Research | Maintains | Buy |
| 2022-11-17 | TD Research | Downgrade | Buy |
| 2022-11-17 | STA Research | Downgrade | Buy |
| 2022-11-16 | TD Research | Downgrade | |
| 2022-10-18 | STA Research | Maintains | Underperform |
| 2022-10-03 | Scotiabank Capital | Upgrade | Outperform |
| 2022-09-27 | Stifel Nicolaus Research | Maintains | Buy |
| 2022-09-27 | STA Research | Maintains | Underperform |
| 2022-09-12 | Stifel Nicolaus Research | Upgrade | |
| 2022-09-12 | National Bank of Canada Financial | Upgrade | Outperform |
| 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.867B 16.12% | 6.413B 9.30% | 7.256B 13.14% | 8.18B 12.74% | 8.73B 6.72% | 9.246B 5.91% | 10.517B 13.75% | 11.485B 9.20% | 12.331B 7.37% | 13.241B 7.38% | 14.208B 7.30% | |
| EBITDA YoY % growth | 1.786B 20.71% | 1.992B 11.54% | 2.206B 10.76% | 2.609B 18.25% | 2.87B 10.00% | 3.116B 8.57% | 3.717B 19.29% | 4.203B 13.08% | 4.696B 11.73% | 5.275B 12.33% | 5.899B 11.83% | |
| EBIT YoY % growth | 1.42B 23.76% | 1.581B 11.29% | 1.746B 10.47% | 2.122B 21.51% | 2.314B 9.05% | 2.539B 9.72% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | 24.21% | 24.65% | 24.07% | 25.94% | 26.51% | 27.46% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 3.56 28.99% | 4.17 17.13% | 4.71 12.95% | 5.15 9.24% | 5.82 13.17% | 6.88 18.14% | 8.22 19.43% | 9.59 16.76% | 11.20 16.80% | 12.96 15.68% | 15.07 16.26% |
All data in CAD
| Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.01 6.03% | 1.29 10.93% | 1.27 8.42% | 1.60 11.81% | 1.13 12.31% | 1.44 11.91% | 1.44 13.85% | 1.82 13.89% |
| Revenue Q2Q % growth | 1.845B 21.29% | 2.033B 17.93% | 2.047B 7.20% | 2.271B 8.08% | 1.969B 6.72% | 2.173B 6.89% | 2.194B 7.18% | 2.423B 6.69% |
| EBITDA Q2Q % growth | 547.9M 22.98% | 651.93M 0.73% | 648.92M -15.91% | 766.49M -21.30% | 605.58M 10.53% | 721.12M 10.61% | 720.02M 10.96% | 856.36M 11.72% |
| EBIT Q2Q % growth | 430.91M 23.66% | 530.61M 19.20% | 527.32M 20.18% | 640.4M 24.61% | 475.76M 10.41% | 584.73M 10.20% | 581.21M 10.22% | 710.82M 11.00% |
All data in CAD
20 analysts have analysed DOL.CA and the average price target is 205.16 CAD. This implies a price increase of 17.91% is expected in the next year compared to the current price of 174.
DOLLARAMA INC (DOL.CA) will report earnings on 2026-06-09.
The consensus EPS estimate for the next earnings of DOLLARAMA INC (DOL.CA) is 1.01 CAD and the consensus revenue estimate is 1.84B CAD.
The expected long term growth rate for DOLLARAMA INC (DOL.CA) is 8.14%.